SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
momo-T/FIF
An SI Board Since October 2003
Posts SubjectMarks Bans
12215 138 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
11040This Stephen Miller is HILARIOUS.scaram(o)uche-2/12/2017
11039Re CARA... <>> since the stock has almost four bagged off of lows <Biotech Jim12/10/2017
11038Hey, thanks for commenting. Best! Rickscaram(o)uche-2/9/2017
11037I think that VK2809 has chance for GSD 1a and broader NASH, but there is signifMiljenko Zuanic-2/9/2017
11036cdec.water.ca.gov Another storm hitting now.scaram(o)uche12/9/2017
11035vktx.... I believe that it was MZ who brought it to the thread? They have nescaram(o)uche-2/9/2017
11034>> since the stock has almost four bagged off of lows << And at thoscaram(o)uche-2/9/2017
11033PIRS Anticalins The technology lends itself to bispecifics, and indeed, much oftuck-2/9/2017
11032Re: CARA competition Hey, BJ, With CARA's readouts coming up soon, we ctuck-2/9/2017
11031Would also be interested in what folks think of Piers' (PIRS) Anticalin techtuck-2/7/2017
11030So here's another under the radar outfit, which is a 5% allocation in my chatuck-2/7/2017
11029mabvax.com (select 10 year chart) Afraid IEDDA is above my pay grade. The comscaram(o)uche-1/25/2017
11028Latest from MabVax: >>Establishment of the In Vivo Efficacy of Pretargetetuck-1/23/2017
11027>> my hobbies are getting in the way of my investing due diligence <<scaram(o)uche-1/11/2017
11026Hi RIck, and best to you in 2017! Especially your hard charging track and fieldBiotech Jim-1/11/2017
11025Thanks, that certainly wasn't on the website, and I hadn't gotten as fartuck-1/11/2017
11024ncbi.nlm.nih.govscaram(o)uche-1/11/2017
11023>>There was a small efficacy trial built into phase I for the xene/Genentetuck-1/11/2017
11022Thanks, B.J. Studies of that sort are badly needed, I agree. I will scour it ascaram(o)uche-1/10/2017
11021Merger of two small companies, Mast and Savara. The smaller one, Mast (MSTX), hA.J. Mullen-1/9/2017
11020I thought this article could clear up a WHOLE LOT of confusion on compounds thaBiotech Jim-1/8/2017
11019Hi Tuck, I think you are talking about Telotristat ethy, treatment for carcinoiMiljenko Zuanic-12/28/2016
11018Hey, Miljenko, Hope your holidays are going joyfully! Somewhere is a post of ytuck-12/27/2016
11017Happy Holidays, all! Wishing you the best of festivities, mindful considerationscaram(o)uche312/24/2016
11016DVAX..... 8-K out. They entered an agreement to sell $100m of secured senscaram(o)uche-12/23/2016
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News